Hemogram-derived ratios as prognostic markers for major adverse cardiovascular events in patients with non-ST-segment elevation myocardial infarction

Table 3 Comparative analysis of hematological-derived ratios between major adverse cardiovascular event group and controls, median (25^th-75^th percentiles)

HDR	Time	MACE	Control	P value
NLR	T1	4.394 (2.974-7.432)	4.179 (2.534-7.715)	0.537
	T2	3.804 (2.231-7.092)	3.053 (2.186-4.903)	0.070
dNLR	T1	2.775 (1.803-4.643)	2.258 (1.669-4.204)	0.214
	T2	2.486 (1.481-4.377)	1.915 (1.430-3.088)	0.100
NPR	T1	0.031 (0.024-0.041)	0.029 (0.020-0.047)	0.685
	T2	0.028 (0.020-0.042)	0.024 (0.018-0.039)	0.103
NLPR	T1	0.020 (0.012-0.032)	0.018 (0.012-0.037)	0.762
	T2	0.017 (0.010-0.034)	0.013 (0.009-0.024)	0.086
PLR	T1	152.678 (95.053-238.760)	138.596 (100.865-187.930)	0.597
	T2	147.935 (92.642-219.337)	120.218 (93.713-169.146)	0.259
MNR	T1	0.095 (0.060-0.141)	0.119 (0.081-0.145)	0.088
	T2	0.111 (0.076-0.158)	0.138 (0.105-0.168)	0.022
MLR	T1	0.432 (0.279-0.639)	0.453 (0.304-0.664)	0.407
	T2	0.441 (0.285-0.628)	0.389 (0.308-0.628)	0.692
LMR	T1	2.315 (1.564-3.586)	2.207 (1.507-3.286)	0.407
	T2	2.270 (1.593-3.504)	2.572 (1.592-3.243)	0.692
LCR	T1	0.180 (0.041-0.642)	0.180 (0.046-0.800)	0.551
	T2	0.103 (0.021-0.356)	0.139 (0.031-0.391)	0.194
CRP/Ly	T1	5.539 (1.418-24.320)	5.347 (1.233-20.531)	0.556
	T2	9.664 (2.813-47.006)	7.172 (2.559-32.454)	0.194
SII	T1	1044.079 (588.656-1812.658)	933.499 (553.663-1471.157)	0.355
	T2	935.137 (467.116-1778.563)	636.296 (458.472-1214.234)	0.071
AISI	T1	730.143 (392.295-1399.338)	619.153 (367.070-1231.876)	0.663
	T2	645.503 (306.489-1525.542)	509.665 (265.857-831.593)	0.121
SIRI	T1	2.795 (1.767-4.904)	2.955 (1.585-5.844)	0.968
	T2	2.576 (1.511-6.067)	2.124 (1.359-4.433)	0.144

HDR: Hematological-derived ratios; NLR: Neutrophil-to-lymphocyte ratio; dNLR: Derived neutrophil-to-lymphocyte ratio; NPR: Neutrophil-to-platelet ratio; NLPR: Neutrophil-to-lymphocyte and platelet ratio; PLR: Platelet-to-lymphocyte ratio; MNR: Monocyte to neutrophil ratio; MLR: Monocyte/lymphocyte ratio; LMR: Lymphocyte-to-monocyte ratio; LCR: Lymphocyte to C-reactive protein ratio; CRP/Ly: C-reactive protein-to-lymphocyte ratio; SII: Systemic immune inflammation index; AISI: Aggregate index of systemic inflammation; SIRI: Systemic inflammation response index; T1: Analysis at admission; T2: Analysis after 24 hours.